Government sets possible R&D spending criteria

Published: 2012-03-13 06:59:00

Updated: 2012-03-13 06:59:00

The Ministry of Health and Welfare has unveiled an ambitious vision to foster global pharmaceutical firms by providing a total of 146 billion won in subsidies to “innovative pharmaceutical firms” that post more than 100 billion won in sales and invest at least 5 percent of their revenue in resear...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK